51±¾É«

Tabea Reith studied Biochemistry at the University of Ulm (2020-2026). During her Bachelor’s she completed an exchange year at the University of Windsor, Canada, and visited Riga Stradiņš University, Latvia, for a summer school and an internship. For her Bachelor’s thesis, she investigated the Bruton’s tyrosine kinase (BTK) variant T316A, which is associated with resistance to the drug ibrutinib in patients with chronic lymphocytic leukemia (CLL). In her Master’s thesis, she expressed engineered murine complement regulators fused to murine serum albumin in Pichia pastoris, followed by protein purification and in vitro characterization. 
Since September 2026, she has been working in the Department of Clinical and Biological Psychology, where she investigates immunometabolism in psychiatric disorders using metabolic fluorescence lifetime imaging microscopy (FLIM).